Denmark· DK-28104733810

Tilmicosol

A qj01fa91 product containing tilmicosinphosphat, registered in Denmark by LAVET Pharmaceuticals Ltd..

ATC QJ01FA91

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedTilmicosolATCQJ01FA91REGISTER NO.DK-28104733810PACKS LISTED1CHECKEDJune 5, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
TILMICOSINPHOSPHAT
Manufacturer
LAVET Pharmaceuticals Ltd.
Country
Denmark (DK)
ATC code
QJ01FA91
ATC class
QJ01FA91
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
June 5, 2026

Packs & prices · 1

  • dk_varenummer
    28104733810

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tilmicosinphosphat in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tilmicosinphosphat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6b84ef45-074c-440d-8b42-ff6129894432
GET /v1/drugs/6b84ef45-074c-440d-8b42-ff6129894432?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "koncentrat til oral opløsning til brug i drikkevand",
  "source": "dkma",
  "strength": "250 mg/ml",
  "auth_role": "CMS",
  "dk_drugid": "28104733810",
  "substance": "TILMICOSINPHOSPHAT",
  "auth_procedure": "MRP",
  "in_medicinpriser": true,
  "registration_date_serial": "40576"
}

See everything about tilmicosinphosphat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.